Referred to the House Committee on Energy and Commerce.
The American Genetic Privacy Act of 2025 prohibits the sale or disclosure of genetic information originally obtained from commercial DNA testing services to the People’s Republic of China or entities under its influence, control, or ownership. The ban covers individual and aggregated genetic information.
Liberals want broader privacy coverage and research exceptions
Relative to its intended legislative type, this bill is a focused substantive change that clearly prohibits certain transfers of genetic information and ties enforcement to the Federal Trade Commission.
The American Genetic Privacy Act of 2025 prohibits the sale or disclosure of genetic information originally obtained from commercial DNA testing services to the People’s Republic of China or entities under its influence, control, or ownership.
The ban covers individual and aggregated genetic information.
Violations are treated as unfair or deceptive acts under the Federal Trade Commission Act, giving the FTC enforcement authority and remedies.
Technically narrow and enforceable by FTC, with cross-cutting national-security appeal, but procedural and legal uncertainties lower odds.
Relative to its intended legislative type, this bill is a focused substantive change that clearly prohibits certain transfers of genetic information and ties enforcement to the Federal Trade Commission. It integrates with existing statutes for definitions and enforcement authority but leaves several operationally significant terms undefined and omits fiscal and implementation detail.
Liberals want broader privacy coverage and research exceptions
These are examples from the analysis, not a ranked list of the most-affected groups.
Liberals want broader privacy coverage and research exceptions
Generally supportive because it protects individuals' genetic privacy and restricts access by a foreign government.
Likely to praise the consumer-privacy and civil-liberties rationale.
May criticize the bill for being narrowly focused on the People’s Republic of China rather than creating broader, stronger privacy protections.
Cautiously supportive as a targeted national-security and consumer-privacy measure using established FTC authority.
Wants clearer definitions, implementation details, and assessment of compliance costs.
Would favor adjustments to reduce uncertain business impacts and ensure enforceability.
Likely supportive because it restricts PRC access to American genetic databases and advances national-security goals.
However, concerned about expanding FTC regulatory power and imposing burdens on U.S. businesses and biotech competitiveness.
Would prefer narrower regulatory mechanisms or criminal penalties.
Reached or meaningfully advanced
Reached or meaningfully advanced
Still ahead
Still ahead
Still ahead
Technically narrow and enforceable by FTC, with cross-cutting national-security appeal, but procedural and legal uncertainties lower odds.
The bill has not accumulated any surfaced votes yet.
Liberals want broader privacy coverage and research exceptions
Technically narrow and enforceable by FTC, with cross-cutting national-security appeal, but procedural and legal uncertainties lower odds.
Relative to its intended legislative type, this bill is a focused substantive change that clearly prohibits certain transfers of genetic information and ties enforcement to the Federal Trade Commission. It integrates wi…
Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.